Kindlin-2 expression has been found to be dysregulated in several cancer types: prostate74-77 breast64,78-80, lung65,81, colorectal cancer82, pancreas83,84 ovarian85,86, esophageal squamous cell carcinoma87-89, liver90, brain91, gastric cancer92,93, bladder94, and acute myeloid leukemia95. This evidence concerns the gene FERMT2 and cancer.